Johnson & Johnson Raises 2021 Sales, Earnings Guidance
July 21 2021 - 6:00AM
Dow Jones News
By Matt Grossman
Johnson & Johnson on Wednesday raised its guidance for
adjusted earnings and for revenue growth in 2021.
The New Brunswick, N.J.-based pharmaceutical company said it now
expects adjusted earnings of $9.60 to $9.70 a share this year. In
April, it had forecast adjusted earnings of $9.42 to $9.57 a
share.
The company said it now expects sales of $93.8 billion to $94.6
billion. In April, it had forecast sales of $90.6 billion to $91.6
billion.
The earnings and sales forecasts include estimates of J&J's
Covid-19 vaccine operations.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
July 21, 2021 06:58 ET (10:58 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2024 to May 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2023 to May 2024